Subsequent Treatment Sample Clauses

Subsequent Treatment. (Cycles 7+) Study Cycles 7+, Day 1 (CX.D1) (±2 days) • Within 72 hours prior to treatment, collect blood samples for the following analyses: — CBC — Serum chemistry • Problem-oriented PE, including xxxxx xxxxx (T, BP, RR, HR), ECOG performance status assessment, and weight • Administer the following study medications according to the procedures in §7.3 — Cetuximab • Assess adverse events and update concomitant medications Study Cycles 7+, Day 8 (CX.D8) (±1 days) • Administer the following study medications according to the procedures in §7.3 — IP — Cetuximab • Assess adverse events and update concomitant medications Study Cycles 7+, Day 15 (CX.D15) (±1 days) • Administer the following study medications according to the procedures in §7.3 — Cetuximab • Assess adverse events and update concomitant medications Study Cycles 7+, Day 22 (CX.D22) (±1 days) • Administer the following study medications according to the procedures in §7.3 — IP — Cetuximab • Assess adverse events and update concomitant medications Study Cycles 7+, Every 8 Weeks (± 7 days) • Perform CT / MRI of neck, chest, upper abdomen, and other anatomical region(s) of disease using the same technique as baseline and in accordance with the Imaging Manual Imaging should not be delayed in case of missed doses or dose delays.
Sample 1
AutoNDA by SimpleDocs
Subsequent Treatment a. Subsequent treatment is treatment that occurs after the date of the Initial Visit. Subsequent Treatment is limited to one (1) per Injured Worker per day.
Sample 1

Related to Subsequent Treatment

  • Investment treatment 1. Each Contracting Party shall grant in its territory to investments of investors of the other Contracting Party a treatment which is no less favourable than that it grants to investments of its own investors or to investments of investors of any other State, whichever is more favourable to the investor.

  • Xxx Treatment We have not promised you any particular tax outcome from buying or holding the Note.

  • Fair Treatment The College and the Union agree that there shall be no discrimination, restriction, or coercion exercised or practised with respect to any employee for reason of membership or activity in the Union.

  • Emergency Treatment Medically necessary treatment due to an emergency.

  • Denial of Preferential Tariff Treatment The Customs Authority of the importing Party may deny a claim for preferential tariff treatment when:

  • National Treatment In the sectors inscribed in its Schedule, and subject to any conditions and qualifications set out therein, each Party shall accord to services and service suppliers of the other Party treatment no less favourable than that it accords, in like circumstances, to its own services and service suppliers.

  • Medical Treatment Undersigned understands that the Released Parties do not have medical personnel available at the location of the activities. Undersigned hereby grants the Released Parties permission to administer first aid or to authorize emergency medical treatment, if necessary. Undersigned understands and agrees that any such action by the Released Parties shall be subject to the terms of this agreement and release, including any liability arising from the negligence of the Released Parties when administering first aid or authorizing others to do so. Undersigned understands and agrees that the Released Parties do not assume responsibility for any injury or damage which might arise out of or in connection with such authorized emergency medical treatment.

  • Treatment The Asset Representations Reviewer agrees to hold and treat Confidential Information given to it under this Agreement in confidence and under the terms and conditions of this Section 4.08, and will implement and maintain safeguards to further assure the confidentiality of the Confidential Information. The Confidential Information will not, without the prior consent of the Issuer and the Servicer, be disclosed or used by the Asset Representations Reviewer, or its officers, directors, employees, agents, representatives or affiliates, including legal counsel (collectively, the “Information Recipients”) other than for the purposes of performing Reviews of Review Receivables or performing its obligations under this Agreement. The Asset Representations Reviewer agrees that it will not, and will cause its Affiliates to not (i) purchase or sell securities issued by the Seller or its Affiliates or special purpose entities on the basis of Confidential Information or (ii) use the Confidential Information for the preparation of research reports, newsletters or other publications or similar communications.

  • National Treatment and Most-favoured-nation Treatment (1) Each Contracting Party shall accord to investments of investors of the other Contracting Party, treatment which shall not be less favourable than that accorded either to investments of its own or investments of investors of any third State.

  • Equitable Treatment ICANN shall not apply standards, policies, procedures or practices arbitrarily, unjustifiably, or inequitably and shall not single out Registry Operator for disparate treatment unless justified by substantial and reasonable cause.

Time is Money Join Law Insider Premium to draft better contracts faster.